New scan could personalize radiation for thyroid cancer patients
NCT ID NCT00673010
First seen Nov 01, 2025 · Last updated May 04, 2026 · Updated 25 times
Summary
This study tested a special type of radioactive iodine (124-I) to measure how much radiation each thyroid cancer tumor receives during standard treatment with 131-I. Twenty adults with thyroid cancer that had spread were scanned to see if 124-I could predict which tumors would respond to treatment. The goal was to avoid giving unnecessary radiation to patients who wouldn't benefit and to customize doses for those who would.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.